callIcon

Dr. Naveen Padmanabhan

Consultant & Head

MBBS, MS, MRCS(Edin.), MCh (AIIMS, New Delhi )

Fellowship in Peritoneal Surface Malignancy, Osaka Japan 2020

Educational Qualifications:

  • MBBS from Tirunelveli Government Medical College, Tirunelveli (2003-2009)
  • M.S (General Surgery) graduated from Stanley Medical College and Hospital, Chennai (2010-2013)
  • Member of Royal College of Surgeons, Royal College of Surgeons of Edinburgh, December 2013
  • MCh Surgical Oncology from All India Institute of Medical Sciences, New Delhi (2015-2018)

Training Courses

  • 2016 - Training in Operative Laparoscopy at Minimally Invasive Training Center, AIIMS, New Delhi
  • 2018 - Clinical observership in Department of Surgical oncology at University of Chicago, Chicago under Prof Mitchell Posner and Dr Kiran Turaga
  • 2018 - Cadaver Course and Workshop on Cytoreductive surgery and HIPEC. March, 2018 at AIIMS, New Delhi
  • 2018 - Cadaver Course and Workshop on Breast oncoplasty and reconstruction on November, 2018 at AIIMS, New Delhi
  • 2023 - Hands on workshop on Thoracic Oncology and Minimally invasive thoracic surgery

Work Experience

  • Consultant & Head in Surgical Oncology Sringeri Sharada Equitas Hospital Cancer Cum Multi speciality Since Sep 2023
  • Consultant in Surgical Oncology Apollo Cancer Institutes, Chennai, India. October 2021- Sep 2023
  • Associate Consultant in Surgical Oncology Apollo Cancer Institutes, Chennai, India. September 2019- October 2021
  • Junior Consultant in Surgical Oncology Apollo Cancer Institutes, Chennai, India. Sep 2018 to Sep 2019
  • Senior Resident, Surgical Oncology All India Institute of Medical Sciences, New Delhi. July 2015 to July 2018
  • Registrar in Surgical Oncology Apollo Cancer Institutes, Chennai, India August 2013 to March 2015
  • Junior Resident, General surgery Stanley Medical college Hospital, Chennai. April 2010 to May 2013

Publications

  • Padmanabhan N, Ayub, M.F, Hussain, K. et al. Factors influencing Non-sentinel node involvement in Sentinel node positive patients and validation of MSKCC nomogram in Indian breast cancer population. Indian J Surg Oncol 2015 Dec; 6(4): 337-345.
    https://doi.org/10.1007/s13193-015-0431-y
  • Padmanabhan N, Kumar BR, Pookunju AP, et al. Preliminary experience and morbidity analysis of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) from a tertiary cancer center in India. J ClinDiagn Res. 2015 Jun; 9(6): XC09–13. doi: 10.7860/JCDR/2015/14216.6075
  • Padmanabhan N, Subramanyan A, Radhakrishna S. Synchronous bilateral breast cancers. J ClinDiagn Res. 2015 Sep. 9(9) XC 05-08. doi: 10.7860/JCDR/2015/14880.6511
  • Kumar BR, Padmanabhan N, Bose G, Paneer V. A Case Report of Adenoid Cystic Carcinoma of Breast– So Close Yet So Far from Triple Negative Breast Cancer. J ClinDiagn Res. 2015 Jul. 9 (7): XD 01-03. doi:10.7860/JCDR/2015/14283.6164.
  • Ray, MD., Jayakumar, P., Mishra, A., Padmanabhan, N. Schwanomma of Pelvis: A Diagnostic Dilemma. Indian J Gynecol Oncology 2017; 15 (46).
    https://doi.org/10.1007/s40944-017-0133-1
  • Padmanabhan N, Ahmed, S. Kurian, A. et al. Unusual and Aggressive Cause of Gall Bladder Mass—Neuroendocrine Tumor. J Gastrointest Canc 2020 Mar; 51(1):307-310.
    https://doi.org/10.1007/s12029-019-00245-6
  • Padmanabhan N, Kurian, A. et al. Giant Gastroesophageal Leiomyoma: Challenges in Diagnosis and Management. J Gastrointest Canc 2020 Mar; Epub:
    https://10.1007/s12029-020-00387-y
  • Naveen Padmanabhan, Haruaki Ishibashi, Yutaka Yonemura et al. Complete pathological response of high grade appendicular neoplasm induced PseudomyxomaPeritonei (PMP) after neoadjuvant intra-peritoneal chemotherapy: A case report Int J Surg Case Rep. 2020; 72: 117–121.Published online 2020 Jun 6.doi:
    https://dx.doi.org/10.1016%2Fj.ijscr.2020.05.072

Field of Interest

  • Gynecological Oncology
  • Peritoneal Surface malignancies – Cytoreductive surgery and HIPEC, PIPAC
  • Breast cancer – Breast conservation and Reconstructions
  • Head and neck cancers
  • Thyroid cancers
  • Soft tissue tumors